Anemia and hemoglobinopathies

PubMed Free Full Text

Hemolytic anemia

Australia, Europe

• Clinical Epidemiology
  • Epidemiology of Atypical Hemolytic Uremic Syndrome: A Systematic Literature Review [2020]

Canada

• Government of Alberta
  • Alberta public health disease management guidelines : haemolytic uremic syndrome

China

• BMC Nephrology
  • Incidence and cost of haemolytic uraemic syndrome in urban China: a national population-based analysis [2022]

Europe

• European Hematology Association
  • Recommendations regarding splenectomy in hereditary hemolytic anemias [2017]

France

• Blood Advances
  • Drug-induced immune hemolytic anemia: detection of new signals and risk assessment in a nationwide cohort study [2024]

• EuroSurveillance
  • Paediatric haemolytic uraemic syndrome related to Shiga toxin-producing Escherichia coli, an overview of 10 years of surveillance in France, 2007 to 2016 [2019]

India

• Indian Academy of Pediatrics
  • Hemolytic uremic syndrome in a developing country: Consensus guidelines [2019]

International

• American Journal of Hematology
  • Addressing the diagnostic gaps in pyruvate kinase deficiency: Consensus recommendations on the diagnosis of pyruvate kinase deficiency [2019]

• Blood Reviews
  • Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting [2019]

• Bulletin of the World Health Organization
  • New WHO classification of genetic variants causing G6PD deficiency [2024]

• Clinical Pharmacology & Therapeutics
  • Expanded Clinical Pharmacogenetics Implementation Consortium Guideline for Medication Use in the Context of G6PD Genotype [2023]

• Lancet Haematology
  • Diagnosis and management of pyruvate kinase deficiency: international expert guidelines [2024]

Iran

• Iranian Journal of Kidney Diseases
  • The Prevalence and Incidence of Hemolytic Uremic Syndrome in Iran, a Systematic Review and Meta-analysis [2020]

Italy

• Blood Transfusion
  • Second-line therapy in paediatric warm autoimmune haemolytic anaemia. Guidelines from the Associazione Italiana Onco-Ematologia Pediatrica (AIEOP) [2018]
  • Diagnosis and management of newly diagnosed childhood autoimmune haemolytic anaemia. Recommendations from the Red Cell Study Group of the Paediatric Haemato-Oncology Italian Association [2017]

Japan

• Scientific Reports
  • Annual trends in atypical haemolytic uremic syndrome management in Japan and factors influencing early diagnosis and treatment: a retrospective study [2024]

Norway

• BMC Infectious Diseases
  • Clinical features, therapeutic interventions and long-term aspects of hemolytic-uremic syndrome in Norwegian children: a nationwide retrospective study from 1999–2008 [2016]

Republic of Korea

• Journal of Korean Medical Science
  • Epidemiological Study of Hereditary Hemolytic Anemia in the Korean Pediatric Population during 1997–2016: a Nationwide Retrospective Cohort Study [2020]
  • Clinical Practice Guidelines for the Management of Atypical Hemolytic Uremic Syndrome in Korea [2016]

• Korean Journal of Internal Medicine
  • Consensus regarding diagnosis and management of atypical hemolytic uremic syndrome [2020]

Saudi Arabia

• Annals of Thoracic Medicine
  • Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Pulmonary hypertension associated with hemolytic anemia [2014]

Spain

• Nefrología
  • An update for atypical haemolytic uraemic syndrome: Diagnosis and treatment. A consensus document [2015]

Taiwan

• Journal of the Formosan Medical Association
  • Atypical hemolytic uremic syndrome: Consensus of diagnosis and treatment in Taiwan [2023]

Turkey

• Turkish Journal of Pediatrics
  • Management of pediatric hemolytic uremic syndrome [2024]

United Kingdom

• British Society for Haematology
  • The diagnosis and management of primary autoimmune haemolytic anaemia [2017]
  • Guidelines on the management of drug-induced immune and secondary autoimmune, haemolytic anaemia [2017]
  • Guidelines for the diagnosis and management of hereditary spherocytosis – 2011 update [2011]

• National Institute for Health and Care Excellence
  • Iptacopan for treating paroxysmal nocturnal haemoglobinuria [2024]
  • Danicopan with ravulizumab or eculizumab for treating paroxysmal nocturnal haemoglobinuria [2024]
  • Crovalimab for treating paroxysmal nocturnal haemoglobinuria in people 12 years and over [2024]
  • Ravulizumab for treating atypical haemolytic uraemic syndrome [2021]
  • Autoimmune haemolytic anaemia: rituximab [2015]

United States

• American Family Physician
  • Hemolytic Anemia: Evaluation and Differential Diagnosis [2018]

• Journal of Comparative Effectiveness Research
  • The cost-effectiveness of pegcetacoplan in complement treatment-naïve adults with paroxysmal nocturnal hemoglobinuria in the USA [2023]

• National Kidney Foundation
  • An expert discussion on the atypical hemolytic uremic syndrome nomenclature-identifying a road map to precision: a report of a National Kidney Foundation Working Group [2024]

WHO

• World Health Organization
  • WHO information note on delayed haemolytic anaemia following treatment with artesunate [2013]

{Related topics}

• Topic
  • Anemia